Taiwan-made corona vaccine authorities permit emergency use Is it possible to counter China?

Taiwanese authorities have approved the emergency use of a new coronavirus vaccine developed by a Taiwanese pharmaceutical company.

Authorities are also expected to counter China's so-called "vaccine diplomacy" through mass production.

This vaccine is of the type "recombinant protein vaccine" developed by the Taiwanese pharmaceutical company "Medigen Vaccine Biologics".

Before the final third stage clinical trial, the Taiwanese authorities who reviewed the data up to the second stage said that the increase in neutralizing antibodies that suppress the action of the virus is not inferior to that of the AstraZeneca vaccine, and it is also safe. On the 19th, we allowed emergency use for people over the age of 20 without any serious concern.

Although some experts have disputed it, the authorities do not consider it a problem, saying that "the number of people subject to clinical trials is significantly larger than in the normal second stage."

The company plans to conduct a third stage clinical trial overseas in the future.

According to authorities, the vaccine is expected to begin supplying next month, with the company aiming to produce more than 10 million doses by the end of the year.

In Taiwan, another pharmaceutical company is also applying for an emergency use of the vaccine.

President Tsai Ing-wen cites "China's obstruction" as the reason for the delay in procuring vaccines from overseas, and states that "only having the production capacity of important strategic supplies can help both ourselves and others" and mass-produce it. It seems that it is also considering countering China's so-called "vaccine diplomacy" through the conversion.